News
Daratumumab, hyaluronidase-fihj ... 8 [8 doses], every 2 weeks at Weeks 9–16 [4 doses]); stop for high dose chemotherapy and ASCT; (consolidation phase: re-initiate every 2 weeks at Weeks ...
DARZALEX (daratumumab) is a prescription medication used to treat multiple myeloma, a type of blood cancer. It is not a chemotherapy drug but a human IgG1k monoclonal antibody that binds strongly ...
$220,000-a-year drug daratumumab was her “best option”. Unable to afford that, last year she took the second option of a stem cell transplant. Chemotherapy and the transplant improved her ...
Medscape Medical News, December 17, 2024 ASH 2024 Daratumumab Confirmed as SOC for ... 2024 SABCS 2024 Atezolizumab Plus Chemo Misses Mark in TNBC The addition of atezolizumab to neoadjuvant ...
Hosted on MSN11mon
Gilead's Kite, Arcellx share phase 3 trial design for CAR-T multiple myeloma assetInvestigators will have a choice of standard of care regimens such as: pomalidomide, bortezomib, and dexamethasone; daratumumab ... followed by lymphodepleting chemotherapy and a single infusion ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results